Avalyn Pharma Inc.

Filing Date

Apr 29, 2026

Transaction Date

Apr 29, 2026

Accession Number

0001193125-26-193328

Form Type

3

Footnotes

1. (F1)Each share of Series C-1 Convertible Preferred Stock and Series D Convertible Preferred Stock (collectively, the "Preferred Stock") is convertible into Common Stock on a one-for-19.2417 basis at any time at the option of the holder and will automatically convert into the number of shares shown in Column 3 immediately prior to the closing of the Issuer's initial public offering. The Preferred Stock has no expiration date.